Herpesvirus quiescence in neuronal cells IV: Virus activation induced by pituitary adenylate cyclase-activating polypeptide (PACAP) involves the protein kinase A pathway

Journal of NeuroVirology

Volumn 7, Issue 2, 2001, Pages 163-168

  Danaher, R J ^a   Savells Arb, A D ^a   Black, S A ^a   Jacob, R J ^a   Miller, C S ^a  

^a UNIVERSITY OF KENTUCKY COLLEGE OF DENTISTRY   (United States)

Author keywords

Herpes simplex virus; Neuronal; Pituitary adenylate cyclase activating polypeptide (PACAP); Reactivation; Viral latency

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 8 (4 CHLOROPHENYLTHIO) CYCLIC AMP; BUCLADESINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC AMP DERIVATIVE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL STRAIN; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; ENZYME ACTIVATION; HERPES SIMPLEX VIRUS 1; IN VITRO STUDY; MODEL; MOLECULAR MIMICRY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SOMATOSENSORY SYSTEM; VIRUS ACTIVATION; VIRUS INFECTION; VIRUS LATENCY; VIRUS REACTIVATION;

ANIMALS; BUCLADESINE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENCEPHALITIS, HERPES SIMPLEX; ENZYME INHIBITORS; HERPESVIRUS 1, HUMAN; INDOLES; ISOQUINOLINES; MALEIMIDES; NEURONS; NEUROPEPTIDES; PC12 CELLS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; SULFONAMIDES; THIONUCLEOTIDES; VIRUS LATENCY;

ANIMALIA; HERPES; HERPESVIRIDAE; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 0034921680     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280152058825     Document Type: Article

References (47)

1. Pituitary adenylate cyclase-activating polypeptide (PACAP): Discovery and current status of research
2. 1 receptor isoform activation of specific intracellular signaling pathways
3. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells
4. Differentiation induces pituitary adenylate cyclase-activating polypeptide receptor expression in PC-12 cells
5. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, PC12D pheochromocytoma cells
6. Heat stress induce reactivation of herpes simplex virus type 1 from quiescently infected neurally differentiated PC12 cells
7. Establishment of a quiescent herpes simplex virus type 1 infection in neurally differentiated PC12 cells
8. Herpesvirus quiescence in neuronal cells: Antiviral conditions not required to establish and maintain HSV-2 quiescence
9. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6
10. The 38-amino acid form of pituitary adenylate cyclase-activating polypeptide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth
11. Autocrine expression and ontogenetic functions of the PACAP ligand/receptor system during sympathetic development
12. VIP and PACAP: Very important in pain?
13. Differential regulation of Raf-1 and B-Raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells
14. Distribution, molecular characterization of pituitary adenylate cyclase-activating polypeptide and its precursor encoding messenger RNA in human and rat tissues
15. Mechanisms of herpes simplex virus type 1 reactivation
16. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide
17. Inhibition of forskolin-activated adenylate cyclase by ethanol and other solvents
18. Characterization of a nerve growth factor-inducible cellular activity that enhances herpes simplex virus type 1 gene expression and replication of an ICPO null mutant in cells of neural lineage
19. Excitatory action of pituitary adenylate cyclase activating polypeptide on rat sympathetic preganglionic neurons in vivo and in vitro
20. Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) in the mesencephalic trigeminal nucleus of the rat after transsection of the masseteric nerve
21. The 38-amino-acid form of pituitary adenylate cyclase-activating polypeptide induces neurite outgrowth in PC12 cells that is dependent on protein kinase C and extracellular signal-regulated kinase but not on growth factor receptor tyrosine kinase, p21(ras) G protein, and pp60(c-src) cytoplasmic tyrosine kinase
22. Mechanisms of pituitary adenylate cyclase activating polypeptide (PACAP)-induced depolarization of sympathetic superior cervical ganglion (SCG) neurons
23. Molecular aspects of herpes simplex virus I: Latency, reactivation and recurrence
24. Enhanced replication of herpes simplex virus type 1 in human cells
25. Molecular circuitry regulating herpes simplex virus type 1 latency in neurons
26. Isolation of a novel 38 residue hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells
27. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38)
28. The effects of axotomy and preganglionic denervation on the expression of pituitary adenylate cyclase activating polypeptide (PACAP), galanin and PACAP type 1 receptors in the rat superior cervical ganglion
29. Heat shock-induced reactivation of herpes simplex virus type 1 in latently infected mouse trigeminal ganglion cells in dissociated culture
30. Regulation of alpha3 nicotinic acetylcholine receptor subunit mRNA levels by nerve growth factor and cyclic AMP in PC12 cells
31. Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor
32. Repression of viral transcription during herpes simplex virus latency
33. CAMP-analogs promote survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor
34. Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia
35. Activation of adenylate cyclase by the diterpene forskolin does not require the nucleotide regulatory protein
36. Activation of second-messenger pathways reactivates latent herpes simplex virus in neuronal cultures
37. Differential signal transduction by five splice variants of the PACAP receptor
38. Messenger molecules and receptor mRNA in the human trigeminal ganglion
39. Neuronal protection from apoptosis by pituitary adenylate cyclase-activating polypeptide
40. + influx-dependent membrane depolarization in bovine adrenal chromaffin cells
41. Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide increase cytosolic free calcium concentration in cultured rat hippocampal neurons
42. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C
43. Identification of PKC-isoform-specific biological actions using pharmacological approaches
44. Role of protein kinase A and the serine-rich region of herpes simplex virus type 1 ICP4 in viral replication
45. Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intrapancreatic regulator of insulin secretion from islet beta-cells
46. Expression of pituitary adenylate cyclase-activating polypeptide in dorsal root ganglia following axotomy: Time course and coexistence
47. Pituitary adenylate cyclase-activating peptide is upregulated in sensory neurons by inflammation